生物勘探
抗菌剂
抗生素耐药性
抗药性
抗感染药
生物技术
生物
微生物学
抗生素
植物
作者
Cynthia Amaning Danquah,Prince Amankwah Baffour Minkah,Isaiah Osei Duah Junior,Kofi Bonsu Amankwah,Samuel Owusu Somuah
出处
期刊:Antibiotics
[MDPI AG]
日期:2022-02-22
卷期号:11 (3): 285-285
被引量:17
标识
DOI:10.3390/antibiotics11030285
摘要
Antimicrobial resistance is an exigent public health concern owing to the emergence of novel strains of human resistant pathogens and the concurrent rise in multi-drug resistance. An influx of new antimicrobials is urgently required to improve the treatment outcomes of infectious diseases and save lives. Plant metabolites and bioactive compounds from chemical synthesis have found their efficacy to be dwindling, despite some of them being developed as drugs and used to treat human infections for several decades. Microorganisms are considered untapped reservoirs for promising biomolecules with varying structural and functional antimicrobial activity. The advent of cost-effective and convenient model organisms, state-of-the-art molecular biology, omics technology, and machine learning has enhanced the bioprospecting of novel antimicrobial drugs and the identification of new drug targets. This review summarizes antimicrobial compounds isolated from microorganisms and reports on the modern tools and strategies for exploiting promising antimicrobial drug candidates. The investigation identified a plethora of novel compounds from microbial sources with excellent antimicrobial activity against disease-causing human pathogens. Researchers could maximize the use of novel model systems and advanced biomolecular and computational tools in exploiting lead antimicrobials, consequently ameliorating antimicrobial resistance.
科研通智能强力驱动
Strongly Powered by AbleSci AI